发明授权
US08080516B2 Long lasting synthetic exendin-4 peptide conjugates 失效
持久的合成毒蜥外泌肽-4肽缀合物

Long lasting synthetic exendin-4 peptide conjugates
摘要:
Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
公开/授权文献
信息查询
0/0